Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Injections × Clear all

NCT07603791 2026-05-22

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07230405 2026-05-12

A Phase II Study of SKB571 in Patients With Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05816252 2026-01-27

MK-2870-003

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06496490 2025-11-20

A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06962865 2025-07-16

A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06514027 2024-07-23

Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06299371 2024-03-07

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT04571632 2022-09-14

Luscid

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04167774 2019-11-22

Compass-001

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung